Biotech/Life Sciences

 Every new startup I know dreams of being touched by an angel investor. Yet according to the latest Read More

With the economy in a tailspin, we need small businesses to succeed more than ever. While everyone hates adding Read More

Some biotech firms are being forced to mortgage their future to keep the doors open during the credit Read More

“This great Nation will endure as it has endured, will revive and will prosper. So, first of all, Read More

All equity markets are hurting these days, even fast-growing and exclusive ones that involve only high net-worth individuals Read More

This perspective will likely be unpopular here, and while I’m reluctant to say it, I feel I must. There Read More

Biotech startups that need to raise cash sometime in the next 12 to 18 months should get busy Read More

With Wall Street melting, public offering disappearing, over-regulation such as Sarbanes Oxley strangling, and bootstrapping igniting, venture capitalism Read More

It seems the entrepreneur has the impossible task of solving the “Entrepreneurs’ Paradox” (the title of my book that Read More

After looking at VCs, and after managing the European American Angel Club for two years now, I have Read More

Grockit, a San Francisco Learning 2.0 Start-Up has raised its Series B financing. Integral Capital Partners lead the Read More

    You can often tell how high the stakes are in a developing market by the tone Read More

We spoke to Kayte Fischer, President of the UC Berkeley Nanotechnology Club, at the 2008 Berkeley Nanotechnology Forum. Read More

Relationships are typically formed around commonalities. In the old days, people came together because they went to the Read More